Skip to main content
. 2021 Mar 2;10(5):1005. doi: 10.3390/jcm10051005

Figure 2.

Figure 2

Overall survival (OS) and progression-free survival (PFS) of NSCLC patients treated with first-line chemotherapy stratified by GRImT0 (a,b), GRImT1 (c,d) and GRImΔ (e,f) values.